Dementia: Page 2

Cerebrospinal fluid test helps pinpoint dementia disorders

The meta-analysis of studies involving about 10,000 people with neurological disorders showed that neurofilament light protein as measured with a commercially available immunoassay was elevated for people with neurological and psychiatric conditions. Results were broadly similar; however, frontotemporal dementia and HIV-related cognitive decline were differentiated from other dementias, and Parkinson's disease was differentiated from atypical parkinsonian conditions.

June 17, 2019

High cholesterol offers clues in early-onset Alzheimer's disease

The study of 2,125 people, including those with early-onset Alzheimer's disease and controls, found higher mean low-density lipoprotein cholesterol (LDL-C) in a subset of patients with early-onset disease, a type of dementia that strikes before the age of 65.

May 29, 2019

Newly defined dementia disease | Blood-based biomarker for CJD | Metabolic pathway screening in children

Dear LabPulse Member,

May 6, 2019

NIH study outlines pathology of newly defined dementia disorder

Called limbic-predominant age-related TDP-43 encephalopathy (LATE), the condition is characterized by misfolded TDP-43, a protein involved in the regulation of gene expression in the brain, and is associated with a decline in cognitive function.

April 29, 2019